SRPT Financial Statements

Balance sheet, income statement, cash flow, and dividends for Sarepta Therapeutics Inc (SRPT).


$11.61B Market Cap.

As of 03/01/2025 5:00 PM ET (MRY) • Disclaimer

SRPT Market Cap. (MRY)


SRPT Shares Outstanding (MRY)


SRPT Assets (MRY)


Total Assets

$3.96B

Total Liabilities

$2.44B

Total Investments

$384.94M

SRPT Income (MRY)


Revenue

$1.90B

Net Income

$235.24M

Operating Expense

$1.36B

SRPT Cash Flow (MRY)


CF Operations

-$205.79M

CF Investing

$755.56M

CF Financing

$124.81M

SRPT Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

SRPT Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$3,963,173,000 (21.40%)

$3,264,576,000 (4.35%)

$3,128,366,000 (-0.62%)

$3,147,974,000 (5.47%)

Assets Current

$3,073,463,000 (19.16%)

$2,579,331,000 (0.84%)

$2,557,861,000 (-1.78%)

$2,604,099,000 (4.78%)

Assets Non-Current

$889,710,000 (29.84%)

$685,245,000 (20.11%)

$570,505,000 (4.90%)

$543,875,000 (8.88%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$14,239,000 (4.48%)

Shareholders Equity

$1,527,742,000 (77.78%)

$859,337,000 (123.23%)

$384,950,000 (-58.52%)

$928,009,000 (21.82%)

Property Plant & Equipment Net

$488,646,000 (36.84%)

$357,106,000 (45.76%)

$244,991,000 (3.51%)

$236,687,000 (-16.13%)

Cash & Equivalents

$1,103,010,000 (157.45%)

$428,430,000 (-55.68%)

$966,777,000 (-54.31%)

$2,115,869,000 (40.81%)

Accumulated Other Comprehensive Income

-$218,000 (-123.75%)

$918,000 (155.17%)

-$1,664,000 (-8220.00%)

-$20,000 (-766.67%)

Deferred Revenue

$455,256,000 (-6.60%)

$487,416,000 (-15.12%)

$574,244,000 (-13.45%)

$663,488,000 (-11.86%)

Total Investments

$384,945,000 (-69.15%)

$1,247,820,000 (22.02%)

$1,022,597,000 (0%)

$0 (0%)

Investments Current

$251,782,000 (-79.82%)

$1,247,820,000 (22.02%)

$1,022,597,000 (0%)

$0 (0%)

Investments Non-Current

$133,163,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$937,946,000 (82.40%)

$514,227,000 (40.30%)

$366,513,000 (96.83%)

$186,212,000 (-19.72%)

Trade & Non-Trade Receivables

$601,988,000 (50.37%)

$400,327,000 (86.52%)

$214,628,000 (40.29%)

$152,990,000 (50.97%)

Trade & Non-Trade Payables

$214,442,000 (30.03%)

$164,918,000 (72.01%)

$95,875,000 (24.93%)

$76,741,000 (-30.92%)

Accumulated Retained Earnings (Deficit)

-$4,210,974,000 (5.29%)

-$4,446,213,000 (-13.71%)

-$3,910,236,000 (-21.94%)

-$3,206,748,000 (-12.59%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$1,329,597,000 (-4.81%)

$1,396,808,000 (-12.80%)

$1,601,870,000 (40.71%)

$1,138,388,000 (6.11%)

Debt Current

$0 (0%)

$123,328,000 (0%)

$0 (0%)

$0 (0%)

Debt Non-Current

$1,329,597,000 (4.41%)

$1,273,480,000 (-20.50%)

$1,601,870,000 (40.71%)

$1,138,388,000 (6.11%)

Total Liabilities

$2,435,431,000 (1.26%)

$2,405,239,000 (-12.33%)

$2,743,416,000 (23.58%)

$2,219,965,000 (-0.13%)

Liabilities Current

$731,684,000 (11.94%)

$653,659,000 (5.50%)

$619,604,000 (36.86%)

$452,733,000 (8.82%)

Liabilities Non-Current

$1,703,747,000 (-2.73%)

$1,751,580,000 (-17.53%)

$2,123,812,000 (20.18%)

$1,767,232,000 (-2.20%)

SRPT Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$1,901,979,000 (52.97%)

$1,243,336,000 (33.26%)

$933,013,000 (32.93%)

$701,887,000 (29.96%)

Cost of Revenue

$319,099,000 (112.25%)

$150,343,000 (7.40%)

$139,989,000 (44.25%)

$97,049,000 (53.12%)

Selling General & Administrative Expense

$557,872,000 (15.77%)

$481,871,000 (6.75%)

$451,421,000 (59.70%)

$282,660,000 (-11.08%)

Research & Development Expense

$804,522,000 (-8.30%)

$877,387,000 (0.03%)

$877,090,000 (13.73%)

$771,182,000 (6.76%)

Operating Expenses

$1,364,799,000 (0.29%)

$1,360,817,000 (2.38%)

$1,329,225,000 (24.86%)

$1,064,548,000 (2.27%)

Interest Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Income Tax Expense

$25,535,000 (60.81%)

$15,879,000 (17.40%)

$13,525,000 (8150.60%)

-$168,000 (-115.80%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

$235,239,000 (143.89%)

-$535,977,000 (23.81%)

-$703,488,000 (-67.99%)

-$418,780,000 (24.43%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

$235,239,000 (143.89%)

-$535,977,000 (23.81%)

-$703,488,000 (-67.99%)

-$418,780,000 (24.43%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

$235,239,000 (143.89%)

-$535,977,000 (23.81%)

-$703,488,000 (-67.99%)

-$418,780,000 (24.43%)

Weighted Average Shares

$95,075,000 (2.90%)

$92,398,000 (5.53%)

$87,559,000 (7.75%)

$81,262,000 (4.24%)

Weighted Average Shares Diluted

$107,875,000 (16.75%)

$92,398,000 (5.53%)

$87,559,000 (7.75%)

$81,262,000 (4.24%)

Earning Before Interest & Taxes (EBIT)

$260,774,000 (150.14%)

-$520,098,000 (24.62%)

-$689,963,000 (-64.69%)

-$418,948,000 (24.25%)

Gross Profit

$1,582,880,000 (44.82%)

$1,092,993,000 (37.83%)

$793,024,000 (31.11%)

$604,838,000 (26.88%)

Operating Income

$218,081,000 (181.43%)

-$267,824,000 (50.05%)

-$536,201,000 (-16.64%)

-$459,710,000 (18.51%)

SRPT Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$755,561,000 (555.70%)

-$165,803,000 (84.16%)

-$1,046,883,000 (-311.32%)

$495,413,000 (507.01%)

Net Cash Flow from Financing

$124,806,000 (-0.16%)

$125,004,000 (-46.24%)

$232,507,000 (-58.60%)

$561,569,000 (-17.70%)

Net Cash Flow from Operations

-$205,787,000 (58.92%)

-$500,993,000 (-53.99%)

-$325,346,000 (26.59%)

-$443,172,000 (-512.38%)

Net Cash Flow / Change in Cash & Cash Equivalents

$674,580,000 (224.51%)

-$541,792,000 (52.46%)

-$1,139,722,000 (-285.68%)

$613,810,000 (-8.12%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$98,000,000 (0%)

$0 (0%)

$102,000,000 (-5.62%)

Net Cash Flow - Investment Acquisitions and Disposals

$902,517,000 (611.46%)

-$176,458,000 (82.59%)

-$1,013,632,000 (-332.48%)

$436,012,000 (402.60%)

Capital Expenditure

-$136,956,000 (-79.95%)

-$76,106,000 (-146.91%)

-$30,824,000 (19.92%)

-$38,490,000 (53.18%)

Issuance (Repayment) of Debt Securities

$45,281,000 (0%)

$0 (0%)

$303,452,000 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$79,525,000 (55.18%)

$51,246,000 (70.58%)

$30,043,000 (-94.72%)

$569,334,000 (43.77%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$184,300,000 (0.98%)

$182,514,000 (-21.67%)

$233,018,000 (104.50%)

$113,943,000 (5.43%)

Depreciation Amortization & Accretion

$53,891,000 (-8.49%)

$58,892,000 (7.86%)

$54,599,000 (10.65%)

$49,342,000 (24.17%)

SRPT Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

83.20% (-5.35%)

87.90% (3.41%)

85.00% (-1.39%)

86.20% (-2.38%)

Profit Margin

12.40% (128.77%)

-43.10% (42.84%)

-75.40% (-26.30%)

-59.70% (41.81%)

EBITDA Margin

16.50% (144.47%)

-37.10% (45.52%)

-68.10% (-29.22%)

-52.70% (44.53%)

Return on Average Equity (ROAE)

19.70% (128.26%)

-69.70% (40.58%)

-117.30% (-69.26%)

-69.30% (-20.10%)

Return on Average Assets (ROAA)

6.60% (138.60%)

-17.10% (25.00%)

-22.80% (-54.05%)

-14.80% (22.51%)

Return on Sales (ROS)

13.70% (132.78%)

-41.80% (43.44%)

-73.90% (-23.79%)

-59.70% (41.70%)

Return on Invested Capital (ROIC)

7.00% (144.30%)

-15.80% (34.71%)

-24.20% (-6.61%)

-22.70% (27.48%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

49.23 (396.08%)

-16.63 (-3.03%)

-16.14 (7.71%)

-17.48 (27.08%)

Price to Sales Ratio (P/S)

6.08 (-15.18%)

7.17 (-41.07%)

12.16 (16.63%)

10.43 (-57.63%)

Price to Book Ratio (P/B)

7.6 (-27.58%)

10.5 (-64.48%)

29.55 (249.69%)

8.45 (-52.16%)

Debt to Equity Ratio (D/E)

1.59 (-43.05%)

2.8 (-60.73%)

7.13 (197.95%)

2.39 (-18.03%)

Earnings Per Share (EPS)

2.47 (142.59%)

-5.8 (27.77%)

-8.03 (-55.92%)

-5.15 (27.57%)

Sales Per Share (SPS)

20 (48.67%)

13.46 (26.28%)

10.66 (23.38%)

8.64 (24.67%)

Free Cash Flow Per Share (FCFPS)

-3.6 (42.28%)

-6.25 (-53.54%)

-4.07 (31.36%)

-5.93 (-1929.32%)

Book Value Per Share (BVPS)

16.07 (72.78%)

9.3 (111.56%)

4.4 (-61.51%)

11.42 (16.86%)

Tangible Assets Book Value Per Share (TABVPS)

41.69 (17.98%)

35.33 (-1.11%)

35.73 (-7.35%)

38.56 (1.18%)

Enterprise Value Over EBIT (EV/EBIT)

49 (357.89%)

-19 (-11.76%)

-17 (5.56%)

-18 (21.74%)

Enterprise Value Over EBITDA (EV/EBITDA)

40.72 (290.67%)

-21.36 (-13.90%)

-18.75 (6.35%)

-20.02 (19.37%)

Asset Turnover

0.54 (35.10%)

0.4 (31.13%)

0.3 (21.77%)

0.25 (33.33%)

Current Ratio

4.2 (6.46%)

3.95 (-4.41%)

4.13 (-28.23%)

5.75 (-3.72%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$342,743,000 (40.61%)

-$577,099,000 (-62.03%)

-$356,170,000 (26.05%)

-$481,662,000 (-2006.52%)

Enterprise Value (EV)

$12,813,948,244 (30.09%)

$9,850,281,449 (-17.32%)

$11,914,241,198 (60.99%)

$7,400,503,466 (-41.95%)

Earnings Before Tax (EBT)

$260,774,000 (150.14%)

-$520,098,000 (24.62%)

-$689,963,000 (-64.69%)

-$418,948,000 (24.25%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

$314,665,000 (168.23%)

-$461,206,000 (27.41%)

-$635,364,000 (-71.90%)

-$369,606,000 (28.00%)

Invested Capital

$3,458,076,000 (-3.39%)

$3,579,295,000 (13.85%)

$3,143,855,000 (84.55%)

$1,703,521,000 (-19.84%)

Working Capital

$2,341,779,000 (21.61%)

$1,925,672,000 (-0.65%)

$1,938,257,000 (-9.91%)

$2,151,366,000 (3.97%)

Tangible Asset Value

$3,963,173,000 (21.40%)

$3,264,576,000 (4.35%)

$3,128,366,000 (-0.17%)

$3,133,735,000 (5.47%)

Market Capitalization

$11,614,234,244 (28.75%)

$9,020,706,449 (-20.70%)

$11,374,866,198 (45.06%)

$7,841,276,466 (-41.72%)

Average Equity

$1,196,768,500 (55.53%)

$769,463,500 (28.29%)

$599,783,250 (-0.78%)

$604,522,500 (-37.05%)

Average Assets

$3,552,937,250 (13.15%)

$3,139,989,750 (1.80%)

$3,084,380,500 (8.85%)

$2,833,624,500 (-2.25%)

Invested Capital Average

$3,712,007,500 (12.94%)

$3,286,819,250 (15.08%)

$2,856,190,250 (54.92%)

$1,843,645,500 (4.35%)

Shares

95,519,650 (2.11%)

93,546,681 (6.57%)

87,782,576 (0.81%)

87,076,918 (10.35%)